LEP and ovarian cancer: Uddin et al. [111] used plate-seeded ovarian cancer cells of the SKOV-3 and MDAH2774 lines and, after a specified period, added leptin-containing medium at a concentration of 100 ng/mL to a part of the plates as a test sample and added leptin-free medium to the other part of the plates as a control.